1/13/2022 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME TSITOVIR-3 (INTERNATIONAL NON-PROPRIETARY NAME ALPHA-GLUTAMIL-TRYPTOPHAN+ASCORBIC ACID+BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE SUBSTANCES: | 1073.1 | 237405.5 | Finland | RAUHA | CJSC MBNPK TSITOMED |
1/13/2022 | 3004500002 | MEDICINE FOR MEDICAL USE, TRADE NAME TSITOVIR-3 (INTERNATIONAL NON-PROPRIETARY NAME ALPHA-GLUTAMIL-TRYPTOPHAN+ASCORBIC ACID+BENDAZOL), DOSAGE FORM - CAPSULES, COMPOSITION: ACTIVE SUBSTANCES: | 1767.1 | 233783.5 | Finland | RAUHA | CJSC MBNPK TSITOMED |
1/21/2022 | 3002150000 | MEDICINES IN THE FORM OF A DOSAGE. LEK. FORMS CONTAINING IN QUALITY. ACTION THING-IN IMMUNOLOGICAL PRODUCTS (EPOETIN ALPHA, OBTAINED USING GENETIC ENGINEERING TECHNOLOGY IS A PURIFIED GLYCOPROTEIN), NOT FOR VETERINARY SECTION, PACKAGED. In UPAK. | 25.28 | 109362.3 | Germany | MOSCOW RUSSIA | CJSC SANDOZ |
1/12/2022 | 3002908000 | MONOCLONAL MOUSE ANTIBODIES TO INTERFERON-ALPHA, UNCONJUGATED, LABORATORY REAGENT FOR ANALYSIS IN RESEARCH LABORATORIES, NOT FOR MEDICINE, NOT FOR VETERINARY, NOT A WASTE, NOT A PHARMACEUTICAL SUBSTANCE | 0.1 | 545.26 | United States of America | BREMERHAVEN PORT IN GERMANY | MEDSTANDART LLC |
1/6/2022 | 3002908000 | MONOCLONAL MOUSE ANTIBODIES TO INTERFERON-ALPHA2, LABORATORY REAGENT FOR ANALYSIS IN RESEARCH LABORATORIES, NOT FOR | 0.1 | 384.85 | United States of America | MOSCOW RUSSIA | RUSMEDTORG LLC |
1/25/2022 | 3002120004 | DRUG FOR MEDICAL USE FOR RETAIL (VED, V1): ADVATE (OCTOKOG ALPHA) LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS ADMINISTRATION 1000 IU | 4349 | 6831792.7 | Austria | T P DAVYDOVSKY D LESHKOVO | PHARMSTANDART JSC |
1/12/2022 | 3002150000 | IMMUNOLOGICAL PRODUCTS PACKED IN DOSAGE FORMS OR IN FORMS OR PACKAGING FOR RETAIL: RESPICAMR (ALPHA 1-PROTEINASE INHIBITOR) (HUMAN) (SOLUTION FOR INFUSION, 20MG/ML (VIAL) 50 ML X FILTER 1 + (NEEDLE WITH FILTER) | 663.69 | 9374312.4 | Israel | MOSCOW RUSSIA | LANCET JSC |
1/20/2022 | 3002120004 | DRUG FOR MEDICAL USE FOR RETAIL (VED, V1): ADVATE (OCTOKOG ALPHA) LYOPHILIZATE FOR PREPARING SOLUTION FOR INTRAVENOUS ADMINISTRATION 500 IU | 3772 | 2980272.2 | Austria | T P DAVYDOVSKY D LESHKOVO | PHARMSTANDART JSC |
1/20/2022 | 3002120004 | DRUG FOR MEDICAL USE FOR RETAIL (VED, V1): ADVATE (OCTOKOG ALPHA) LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS ADMINISTRATION 1000 IU | 1750 | 2767692.2 | Austria | T P DAVYDOVSKY D LESHKOVO | PHARMSTANDART JSC |
1/19/2022 | 3002140000 | TUMOR NECROSIS FACTOR ALPHA, REV. PROTEIN, 10 mcg, NON-PHARM. SUBSTANCE, NOT A MEDICINE, NOT FOR VETERINARY SCIENCE, FOR LABORATORY STUDIES CJSC BIOCAD , DRY ICE IS USED IN PACKAGING | 0.06 | 1075 | Israel | VILNIUS AIRPORT LITHUANIA | CJSC BIOCAD |